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Although it has been established since the 1970s that
deletions of the long arm of the Y chromosome are as-
sociated with spermatogenic failure, only in the last few
years have these regions been described at the molecular
level. In parallel, Y-linked genes and gene families that
may explain the phenotypes of men carrying these de-
letions have been identified. The first association be-
tween spermatogenic failure and an underlying genetic
cause was demonstrated by Tiepolo and Zuffardi (1976)
in a report of six azoospermic patients carrying micro-
scopically detectable deletions of the distal portion of
Yq. In four patients, the deletion was de novo—that is,
their fathers were tested and were found to carry intact
Y chromosomes. On this basis, Tiepolo and Zuffardi
(1976) proposed the existence of a spermatogenesis fac-
tor, called the “azoospermia factor” (AZF), encoded by
a gene on distal Yq. However, the assumption that AZF
represented a single Y-linked gene was overturned when
Vogt et al. (1996) observed that Y chromosome micro-
deletions follow a certain deletion pattern, with three
recurrently deleted nonoverlapping subregions in prox-
imal, middle, and distal Yq11, designated “AZFa,”
“AZFb,” and “AZFc,” respectively. In addition, it be-
came clear that these deletions were not exclusively as-
sociated with azoospermia (Reijo et al. 1996a). Dele-
tions are associated with a wide range of histological
profiles, from Sertoli cell–only syndrome (SCOS) to sper-
matogenic arrest (SGA) and severe hypospermatogene-
sis. The physical size of these regions has been estimated
to be 1–3 Mb for AZFa and AZFb and ∼1.4 Mb for
AZFc. Recent studies have shown that ∼10%–15% of
azoospermic and ∼5%-10% of severely oligozoospermic
men have Yq microdeletions. However, despite these ad-
vances, there are still many unanswered questions,which
are the subject of this review.
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Deletion Frequency and Genotype/Phenotype
Correlations
Several combined clinical and molecular studies have
sought (1) to define recurrently deleted regions of Yq,
(2) to determine the incidence of microdeletions among
azoospermic and oligozoospermic men, and (3) to cor-
relate the size and position of the deletions that cause
the infertile phenotype. The reported incidence of mi-
crodeletions in infertile men varies enormously between
studies, within the range 1%–55% (Reijo et al. 1995;
Quereshi et al. 1996; Stuppia et al. 1996, 1997; Foresta
et al. 1997, 1998; Pryor et al. 1997; Simoni et al. 1997;
Van der Vent et al. 1997), but study design probably
accounts for much of this variation. Study populations
have included azoospermic patients, azoospermic and
oligozoospermic patients, or azoospermic/oligozoosper-
mic and infertile normospermic patients. Most clinical
studies “select” individuals with idiopathic azoospermia
or oligozoospermia, although others include “unse-
lected” infertile men with known or unknown causes of
infertility. Unfortunately, however, there is no general
agreement on what constitutes idiopathic infertility. Var-
icocele and history of cryptorchidism are considered id-
iopathic in some studies and nonidiopathic in others.
Variation in reported deletion frequency also seems to
be affected by the number of patients in the study; in
general, studies with low patient numbers report a higher
deletion frequency, perhaps because these studies select
patients more stringently. Another variable thatmay also
affect Yq deletion frequency is marker density or the
position of markers. Despite these caveats, it is possible
that differences in deletion frequency and/or localiza-
tion, between studies, may reflect genuine geographic or
ethnic differences, perhaps related to a particular Y chro-
mosome haplogroup, the genetic background, or envi-
ronmental influences.
Vogt et al. (1996) originally proposed that AZFa de-
letions result in type I SCOS, in which no spermatogonia
develop, whereas deletions in AZFb cause SGA, usually
at the spermatocyte stage, and deletions in AZFc are
associated with a more variable phenotype, ranging from
type II SCOS (absence of germ cells in most testis tu-
bules) to hypospermatogenesis (presence of all germ-cell
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types, albeit in reduced numbers). In general, subsequent
studies have supported these findings, but there have
been exceptions: both AZFa and AZFb deletions have
been reported in oligozoospermic men, and we have
found oligozoospermia associated with AZFb deletions
(authors’ unpublished data).
Another problem in the definition of genotype/phe-
notype correlations is the variability of the phenotype
in the same man, over time. In one study, an individual
with an AZFc deletion showed a progressive decrease in
sperm concentration, from severe oligozoospermia to
azoospermia, over 30 mo (Girardi et al. 1997). Never-
theless, some patterns have emerged from a survey of
the clinical literature on these deletions. First, micro-
deletions are found almost exclusively in males affected
by azoospermia or severe oligozoospermia or, occasion-
ally, in patients with other abnormal andrological find-
ings. Second, a higher frequency of Yq deletions is found
in azoospermic men, compared with oligozoospermic
men, and in men with well-defined idiopathic infertility,
compared with men for whom the etiology of the in-
fertility is known. Third, large deletions generally are
associated with more-severe spermatogenic defects. Fi-
nally, AZFa deletions, which are relatively uncommon
(frequency of 1%–5%), generally are associated with
SCOS type I, whereas AZFc and AZFcAZFb deletions,
the most frequent form of these lesions, may be asso-
ciated with a variety of spermatogenesis defects, includ-
ing oligozoospermia.
Mechanism of Y Deletions
The relatively high frequency of de novo Y deletions
indicates that the Y chromosome is susceptible to the
spontaneous loss of genetic material. The instability of
the Y chromosome may be related to the high frequency
of repetitive elements clustered along the length of the
chromosome, and deletions may occur through aberrant
recombination events (between areas of homologous or
similar sequence repeats, between the X and Y chro-
mosomes, or by Y chromosome unbalanced sister-chro-
matid exchange) or by slippage during DNA replication.
There also may be particular Y chromosome sequences
that promote deletion of the AZF regions; consequently,
some individuals may be more susceptible to de novo
deletions than are others. Indeed, Jobling et al. (1998)
defined one Y chromosome haplotype that is susceptible
to aberrant X/Y exchange during male meiosis, leading
to Y-positive 46,XX maleness and infertility. Advanced
paternal age also might promote the loss of Y sequences,
although this hypothesis needs to be examined by cor-
relation of deletion incidence with the age of the father
at conception. Paternal age effects have been described
in Marfan syndrome, neurofibromatosis, and Apert syn-
drome. However, in most of these cases, the mutations
are 1-bp substitutions, rather than deletions.
Y-Specific Genes and Gene Families
Several genes and gene families have been identified
on the long arm of the Y chromosome (Lahn and Page
1997; also see Lau 1999 [in this issue]). Some of these
genes fall within AZF deletion intervals and therefore
may underlie the observed deletion phenotypes (tables
1 and 2). These genes can be divided into those that may
be involved in cellular “housekeeping” activities and
those that are expressed solely in the testis. The former
group (table 1) includes Drosophila fats facets related
Y (DFFRY), dead box Y (DBY), ubiquitous tetratrico-
peptide repeat (TPR) motif Y (UTY), the eukaryotic
translation-initiation–factor 1A Y isoform (eIF-1AY), se-
lected mouse cDNA on the Y (SMCY), and the thymosin
b4 Y isoform (Tb4Y). These ubiquitously expressed
genes each exist in a single copy on the Y chromosome,
and each possesses a closely related X-linked homologue
that escapes X inactivation. The testis-specific group
(table 2) includes the RNA-binding–motif Y chromo-
some gene (RBMY) and its relatives, deleted in azoosper-
mia (DAZ), chromodomain Y (CDY), XK-related Y
(XKRY), protein-tyrosine phosphatase BAS-like (PTP-
BL)–related Y (PRY), and the genes for basic proteins
Y1 and Y2 (BPY1 and BPY2). These genes are present
in multiple copies on the Y and do not appear to have
X homologues.
DFFRY, DBY, and UTY all fall within the AZFa de-
letion interval; therefore, one or more of these genesmay
be implicated in SCOS or other male-fertility disorders.
AZFb includes copies of CDY and XKRY, as well as of
SMCY, eIF-1AY, and RBMY. Although sequences related
to RBMY are found throughout the Y chromosome,
functional copies appear to be restricted to AZFb, since
deletions of distal AZFb lead to the absence of RBMY
epitopes in testicular sections (Elliott et al. 1997). A
number of transcripts are found within AZFc. At least
six copies of DAZ are found in this region (Saxena et
al. 1996; Yen et al. 1997), as are multiple copies of PRY,
BPY2, CDY, and XKRY. Any of these genes may con-
tribute to the AZFc-deletion phenotype, and most AZFc
deletions probably remove all these genes. Individuals
with AZFc deletions can present with oligozoospermia,
and some even father children; hence, it is clear that
these genes are not essential for spermatogenesis.
Function of Y-linked Genes in Spermatogenesis
At present, we know very little about the biochemistry
or biology of Y-encoded proteins. Only RBMY andDAZ
have been studied extensively. More than 30 RBMY
genes and pseudogenes occur over both arms of the Y
930 Am. J. Hum. Genet. 64:928–933, 1999
Table 1
Ubiquitously Expressed Housekeeping Genes That Map to AZF-Deleted Regions and That Have Been Implicated
in Male Infertility
Gene
Symbol Gene Name Comment(s)
X-Linked
Homologue
Amino Acid
Identity
(%)
DFFRY Drosophila fats facets related Y Homologous to Drosophila deubi-
quinating enzyme (Brown et al.
1998)
DFFRX 91
DBY Dead box Y Contains a DEAD (amino acid se-
quence Asp-Glu-Ala-Asp) box mo-
tif; may function as an RNA heli-
case (Linder et al. 1989)
DBX 91
Tb4Y Thymosin b4 Y May be involved in actin sequestra-
tion (Gondo et al. 1987)
Tb4X 93
UTY Ubiquitous TPR motif Y Contains 10 tandem TPR motifs that
may be involved in protein-protein
interactions (Greenfield et al. 1996)
UTX 85
SMCY Selected mouse cDNA on the Y Encodes an H-Y antigen epitope
(Agulnik et al. 1994a, 1994b)
SMCX 84
eIF-1AY Eukaryotic translation-initia-
tion–factor 1A
Eukaryotic translation-intiation factor
(Pestova et al. 1998).
eIF1-1AX 98
NOTE.—These genes are present in a single copy on the Y, but they all have X homologues that escapeX inactivation.
In all cases, the degree of sequence identity between the X and Y homologues is 84%.
chromosome (Ma et al. 1993; Prosser et al. 1996; Chai
et al. 1997), and these sequences can be divided into
several subfamilies. The RBMY1 subfamily has at least
seven members, all of which appear to be clustered in
the AZFb region (Prosser et al. 1996; Chai et al. 1997,
1998). These genes encode germ-cell specific nuclear pro-
teins that contain an RNA-binding motif (RBM), as well
as four copies of an SRGY (Serine-Arginine-Glycine-
Tryosine motif) repeat. RBMY2 genes share 88% ho-
mology with RBMY1 genes and encode an RBM and a
single SRGY repeat. The RBMY1 sequence is 67% sim-
ilar to the autosomally expressed hnRNPG (ribonucle-
oprotein G) protein, a nuclear glycoprotein with RNA-
binding activities but with no known biological function
(Soulard et al. 1993). RBMY1 genes may derive from
an hnRNPG gene that translocated to the Y chromo-
some and subsequently was amplified (Delbridge et al.
1997). In humans, RBMY1 can be detected by immu-
nostaining of pachytene spermatocytes, an interesting
observation in view of the SGA often seen in association
with AZFb deletions (Elliott et al. 1997, 1998). In sper-
matocytes, RBMY1 colocalizes with pre–mRNA-splic-
ing components in a discrete area of the nucleus, but,
by late meiosis, it is found diffusely throughout the
nucleoplasm of round spermatids. Hence, RBMY1
may play distinct roles during different phases of
spermatogenesis.
LikeRBMY, DAZ encodes a testis-specific protein that
has a single RBM and a series of 8–24 copies of a
24–amino-acid unit termed the “DAZ repeat” (Reijo et
al. 1995; Yen et al. 1997). The biological function of
this motif is unknown, and DAZ genes differ substan-
tially in the sequence and organization of these repeats
(Yen et al. 1997). DAZ is homologous to an autosomal
gene with a single DAZ repeat, named “DAZL1” (DAZ-
like autosomal 1; Saxena et al. 1996; Yen et al. 1996),
and the Y-linked DAZ probably originated from the
translocation and amplification of this ancestral auto-
somal gene. Mice lack the Y-locatedDAZ gene, but they
do carry a single autosomal Dazl1 gene (Cooke et al.
1996; Reijo et al. 1996b). Immunostaining has revealed
human DAZ in the innermost layer of male germ-cell
epithelium and in the tails of spermatozoa (Habermann
et al. 1998). This observation is consistent with the ex-
pression of DAZ transcripts just inside the perimeter of
seminiferous tubules in spermatogonia (Menke et al.
1997). However, some caution must be used when these
results are interpreted, since cross-hybridization with
DAZL mRNA or protein cannot be excluded.
Insights into human DAZ function may come from
the analysis of its autosomal homologues in other spe-
cies. Targeted disruption of Dazl1 in mice leads to a
complete absence of gamete production in both testis
and ovary, demonstrating that Dazl1 is essential for the
development or survival of germ cells (Ruggiu et al.
1997). In Drosophila, mutation of the boule gene, an-
other homologue of DAZL, results in spermatocyte ar-
rest at the G2/M transition and complete azoospermia
(Castrillon et al. 1993; Eberhart et al. 1996). The boule
protein occurs in the nucleus of primary spermatocytes
until the end of the meiotic prophase, after which it is
found in the cytoplasm. In Xenopus, Xdazl is expressed
in premeiotic germ cells in adult testis (Houston et al.
1998). Interestingly, the Xenopus Xdazl gene can rescue
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Table 2
Genes and Gene Families with Expression Restricted to the Testis and That Map to the AZF-Deleted Regions
of the Y chromosome
Gene
Symbol Gene Name Comment(s)
X-Linked or Autosomal
Homologue
RBMY RNA-binding–motif Y Subfamilies include RBMY1 and
RBMY2; RBMY1 may be functional
and is predicted to bind RNA
RBMY may be an ances-
tral hnRNPG gene
DAZ Deleted in azoospermia Predicted to bind RNA, as Xenopus Dazl
does in vitro
DAZL1 chromosome 3p25
XKRY XK-related Y Similar to XK, a putative membrane-
transport protein (Ho et al. 1994)
None known
CDY Chromodomain Y Contains chromodomain (James and El-
gin 1986); may be involved in chro-
matid modification during
spermatogenesis
None known
PRY PTP-BL–related Y Similar to PTP-BL, a putative membrane-
transport protein (Hendriks et al.
1995)
None known
BPY1 Basic protein Y1 Basic protein of unknown function None known
BPY2 Basic protein Y2 Basic protein of unknown function None known
NOTE.—Table modified from the report by Lahn and Page (1997).
meiotic entry of spermatocytes in Drosophila boulemu-
tants, suggesting functional conservation of the DAZ
family over evolutionary time (Houston et al. 1998).
Xdazl protein has RNA-binding properties in vitro, and
perhaps other members of the DAZ family play a role
in RNA metabolism during gamete development (Hous-
ton et al. 1998).
Other genes on the long arm of the Y also may be
involved in RNA metabolism. DBY is predicted to act
as an RNA helicase (Lahn and Page 1997), and eIF-1AY
encodes an essential translation-initiation factor (Pes-
tova et al. 1998). During the latter stages of spermat-
ogenesis, transcription terminates and posttranscrip-
tional regulation plays a primary role (see reviews by
Braun [1998] and Hecht [1998]). RNA synthesis peaks
during the spermatocyte stage, is gradually reduced in
subsequent stages, and ceases as round spermatids dif-
ferentiate into elongated spermatids. Numerous mRNA
that are under posttranslational control during sper-
matogenesis have been identified. It is tempting to spec-
ulate that many of the factors encoded by Y-linked genes
play key roles in this process.
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